SAM ACTION, INC. for SAM ACTION, INC.

Medical/Disease Research/Clinical Labs MED

H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana

Contacted: Food & Drug Administration (FDA); Justice, Dept of (DOJ); Small Business Administration (SBA); Drug Enforcement Administration (DEA); Natl Institutes of Health (NIH); White House Office; SENATE; HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 3797 (116th), S. 2032 (116th)

Law Enforcement/Crime/Criminal Justice LAW

H.R. 2093/S. 1028, STATES Act to legalize marijuana, appropriations amendments related to marijuana legalization, criminal justice reform related to marijuana, H.R. 3884, MORE Act.

Contacted: Food & Drug Administration (FDA); SENATE; Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Small Business Administration (SBA); White House Office; Justice, Dept of (DOJ)

Bills named: H.R. 2093 (116th), S. 1028 (116th), H.R. 3884 (116th)

Banking BAN

H.R. 1595/S. 1200, SAFE Banking Act on marijuana banking and investment

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); SENATE; Drug Enforcement Administration (DEA); White House Office; Small Business Administration (SBA)

Bills named: S. 1200 (116th), H.R. 1595 (116th)

Alcohol and Drug Abuse ALC

The effects of marijuana on children, the nexus between marijuana and psychosis

Contacted: Food & Drug Administration (FDA); Justice, Dept of (DOJ); SENATE; White House Office; Small Business Administration (SBA); Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES

Small Business SMB

Preventing federally illegal enterprises from gaining a special carve out to access federally subsidized loans or grants.

Contacted: Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); SENATE; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Small Business Administration (SBA); Natl Institutes of Health (NIH); White House Office

Government Issues GOV

federal role in marijuana laws, the legalization of marijuana, criminal justice reform

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP); White House Office; Small Business Administration (SBA); Natl Institutes of Health (NIH); Justice, Dept of (DOJ)

Consumer Issues/Safety/Products CSP

safety issues surrounding marijuana, marketing of high potency marijuana products to children

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Justice, Dept of (DOJ); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); White House Office; SENATE; Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP)

Health Issues HCR

the effects of marijuana on children, pregnant women and developing brains, the nexus between high potency marijuana and mental illness

Contacted: Natl Institutes of Health (NIH); SENATE; White House Office; Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); Justice, Dept of (DOJ); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES